Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.
about
Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain.Icariside II, a novel phosphodiesterase 5 inhibitor, protects against H2 O2 -induced PC12 cells death by inhibiting mitochondria-mediated autophagyThe mechanism of attenuation of epithelial-mesenchymal transition by a phosphodiesterase 5 inhibitor via renal klotho expression.A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice.Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T.
P2860
Q26746978-B19DC03C-6DCC-4B89-B21B-3A4B418B5B28Q37064024-2D94F416-58C0-4C44-95E8-6C47E9FA2B61Q41972250-4D47F564-4BE8-4033-9606-E8B8883702B5Q47844871-023678CE-E183-4D20-BEE0-4DC0DF0334AAQ48557521-E93B82E1-B81C-47CF-807D-DE0BC9677F3BQ48590768-3013CCE1-7BE4-44AD-8FBC-C4043F518DF6Q55408663-2D6AD449-01A4-4C65-854B-6E8F4149068D
P2860
Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetic investigation ...... rebrospinal fluid cGMP levels.
@en
type
label
Pharmacokinetic investigation ...... rebrospinal fluid cGMP levels.
@en
prefLabel
Pharmacokinetic investigation ...... rebrospinal fluid cGMP levels.
@en
P2093
P2860
P50
P356
P1476
Pharmacokinetic investigation ...... rebrospinal fluid cGMP levels.
@en
P2093
Ana Ugarte
Carolina García-Barroso
Iria G Dopeso-Reyes
P2860
P304
P356
10.1111/JNC.13454
P407
P50
P577
2015-12-07T00:00:00Z